This innovative cancer vaccine platform harnesses gamma-delta T cells - a rare immune cell type with natural tumor-targeting abilities. These natural biological messengers deliver targeted cancer signals to train the body's immune system to recognise and destroy tumors. Combining potent anti-tumor effects with ready-to-use convenience, this technology offers a scalable, effective treatment platform applicable across multiple cancer types with significant clinical and commercial potential.
Team of Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine
Prof. Wenwei TU
Professor
Dr. Xiewang WANG
Research Assistant Professor
Dr. Yiping LIU
Research Officer
Email: wutw@hkuhk, xiewang@connect.hku.hk
Gold Medal with Congratulations of Jury, International Exhibition of Inventions Geneva 2025